Mouse Anti-KRT8 Recombinant Antibody (4D12) (CBMAB-K2024-LY)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Human | P05787 |
Nucleus, nucleoplasm By Similarity
Nucleus matrix
A liver disease characterized by severe panlobular liver-cell swelling with Mallory body formation, prominent pericellular fibrosis, and marked deposits of copper. Clinical features include abdomen swelling, jaundice and pulmonary hypertension.
O-glycosylated. O-GlcNAcylation at multiple sites increases solubility, and decreases stability by inducing proteasomal degradation.
O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Mouse Anti-KRT8 Recombinant Antibody (CBT3690) (CAT#: V2LY-0625-LY2281)
Mouse Anti-KRT8 Recombinant Antibody (4A41) (CAT#: CBMAB-C6596-LY)
Mouse Anti-KRT8 Recombinant Antibody (35_H11) (CAT#: CBMAB-AP2970LY)
Mouse Anti-KRT8 Recombinant Antibody (CBWJC-4101) (CAT#: CBMAB-C5440WJ)
Human Anti-KRT8 Recombinant Antibody (CBXC-0937) (CAT#: CBMAB-C2053-CQ)
Mouse Anti-KRT8 Recombinant Antibody (CBWJC-4086) (CAT#: CBMAB-C5422WJ)
Mouse Anti-KRT8 Recombinant Antibody (AE3) (CAT#: CBMAB-C0389-CQ)
Mouse Anti-KRT8 Recombinant Antibody (C-51) (CAT#: CBMAB-C0491-CQ)
Mouse Anti-KRT8 Recombinant Antibody (KRT8/899) (CAT#: CBMAB-K2040-LY)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
